Author

Pablo Martí‐Rodrigo

Observed names: Martí-Rodrigo, Pablo, P. Martí-Rodrigo, Pablo Martí-Rodrigo

Observed institutions: Universitat de València, Science for Life Laboratory, Karolinska Institutet, Biomedical Research Networking Center on Neurodegenerative Diseases, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

ORCID: 0000-0002-1049-0918

Observed ORCID: 0000-0002-1049-0918

OpenAlex ID: A5014871334

Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells

2019 · Alberto Martí-Rodrigo, Fernando Alegre, et al. · Gut · 108

A renal clearable fluorogenic probe for in vivo β-galactosidase activity detection during aging and senolysis

2024 · Sara Rojas-Vázquez, Beatriz Lozano-Torres, et al. · Nature Communications · 47

Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells

2021 · Daniela Hühn, Pablo Martí‐Rodrigo, et al. · Molecular Oncology · 27

Estrogen deprivation triggers an immunosuppressive phenotype in breast cancer cells

2019 · Daniela Hühn, Pablo Martí-Rodrigo, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 8

The antiretroviral rilpivirine induces hepatic regeneration in liver fibrosis and cirrhosis by modulating the STAT3/STAT1 balance

2018 · A. Martí-Rodrigo, Ángela B. Moragrega, et al. · Journal of Hepatology · 1

Author response for "Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells"

2021 · Daniela Hühn, Pablo Martí‐Rodrigo, et al.

Works count: 7

Citation count: 191

H-index: 4

I10-index: 3